Effect of sarcopenia on hospital stay from post cardiac surgery to discharge.
ADL, activities of daily living
BMI, body mass index
BNP, brain natriuretic peptide
CI, confidence interval
CPB, cardiopulmonary bypass
CT, computed tomography
Cardiac surgery
Hospital stay
ICU, intensive care unit
OR, odds ratio
SMI, skeletal muscle mass index
Sarcopenia
eGFR, estimated glomerular filtration rate
Journal
International journal of cardiology. Heart & vasculature
ISSN: 2352-9067
Titre abrégé: Int J Cardiol Heart Vasc
Pays: Ireland
ID NLM: 101649525
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
received:
13
01
2022
revised:
25
02
2022
accepted:
09
03
2022
entrez:
22
3
2022
pubmed:
23
3
2022
medline:
23
3
2022
Statut:
epublish
Résumé
Cardiovascular surgery in older patients with sarcopenia has high rates of major complications, long hospital stays, readmissions, and discharge transfers. However, the factors that influence the length of hospital stay are unknown. This study aimed was to identify the predictors of the prolonged hospital stay in patients with sarcopenia after cardiovascular surgery. A total of 192 patients scheduled for cardiac surgery were enrolled in this retrospective observational study. Sarcopenia was diagnosed preoperatively. Clinical data from the preoperative, intraoperative, and perioperative periods were evaluated to determine the factors influencing the length of hospital stay. The sarcopenia and non-sarcopenia groups differed significantly in age; body mass index; renal function; intubation time; transfusion of red blood cells; hospital transfer; and hemoglobin, brain natriuretic peptide, and albumin levels. Sarcopenia was the most significant factor influencing prolonged postoperative hospital stay, as well as prolonged intubation time. In the sarcopenia group, albumin levels and cardiopulmonary bypass time were the significant factors affecting hospital stay. Sarcopenia was the most significant factor associated with prolonged postoperative hospital stay in patients who underwent cardiac surgery. In addition, improving sarcopenia, nutritional status, and shortening cardiopulmonary bypass time appear to shorten the hospital stay in patients with sarcopenia who underwent cardiovascular surgery.
Sections du résumé
Background
UNASSIGNED
Cardiovascular surgery in older patients with sarcopenia has high rates of major complications, long hospital stays, readmissions, and discharge transfers. However, the factors that influence the length of hospital stay are unknown. This study aimed was to identify the predictors of the prolonged hospital stay in patients with sarcopenia after cardiovascular surgery.
Methods
UNASSIGNED
A total of 192 patients scheduled for cardiac surgery were enrolled in this retrospective observational study. Sarcopenia was diagnosed preoperatively. Clinical data from the preoperative, intraoperative, and perioperative periods were evaluated to determine the factors influencing the length of hospital stay.
Results
UNASSIGNED
The sarcopenia and non-sarcopenia groups differed significantly in age; body mass index; renal function; intubation time; transfusion of red blood cells; hospital transfer; and hemoglobin, brain natriuretic peptide, and albumin levels. Sarcopenia was the most significant factor influencing prolonged postoperative hospital stay, as well as prolonged intubation time. In the sarcopenia group, albumin levels and cardiopulmonary bypass time were the significant factors affecting hospital stay.
Conclusions
UNASSIGNED
Sarcopenia was the most significant factor associated with prolonged postoperative hospital stay in patients who underwent cardiac surgery. In addition, improving sarcopenia, nutritional status, and shortening cardiopulmonary bypass time appear to shorten the hospital stay in patients with sarcopenia who underwent cardiovascular surgery.
Identifiants
pubmed: 35313647
doi: 10.1016/j.ijcha.2022.101003
pii: S2352-9067(22)00052-5
pmc: PMC8933819
doi:
Types de publication
Journal Article
Langues
eng
Pagination
101003Informations de copyright
© 2022 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Maturitas. 2015 May;81(1):17-27
pubmed: 25782627
J Cardiothorac Surg. 2017 Oct 26;12(1):91
pubmed: 29073924
Eur J Cardiothorac Surg. 2017 Jun 1;51(6):1135-1141
pubmed: 28369482
Surgery. 2011 Sep;150(3):505-14
pubmed: 21878237
Heliyon. 2020 Dec 17;6(12):e05759
pubmed: 33364510
Am J Cardiol. 2016 Mar 1;117(5):828-33
pubmed: 26754122
J Cachexia Sarcopenia Muscle. 2014 Dec;5(4):269-77
pubmed: 25223471
Int J Cardiol. 2016 Jul 15;215:301-6
pubmed: 27128551
Eur J Cardiothorac Surg. 2011 Jan;39(1):33-7
pubmed: 20627611
Ann Intern Med. 2016 Nov 1;165(9):650-660
pubmed: 27548070
Md State Med J. 1965 Feb;14:61-5
pubmed: 14258950
J Thorac Cardiovasc Surg. 2019 Mar;157(3):1071-1079.e3
pubmed: 30139644
Int J Cardiol. 2018 Oct 1;268:216-221
pubmed: 29650344
J Am Med Dir Assoc. 2014 Feb;15(2):95-101
pubmed: 24461239
Circ Rep. 2021 Jul 22;3(8):423-430
pubmed: 34414331
BMC Geriatr. 2016 Aug 31;16(1):157
pubmed: 27580947
Am Heart J. 2020 Jun;224:171-181
pubmed: 32416332
Ann Thorac Surg. 2016 Apr;101(4):1318-25
pubmed: 26794887
Exp Gerontol. 2021 Jul 15;150:111379
pubmed: 33930506
Cureus. 2019 Nov 6;11(11):e6088
pubmed: 31857920
Nutrients. 2017 Aug 03;9(8):
pubmed: 28771192
Eur J Cardiovasc Nurs. 2019 Apr;18(4):309-317
pubmed: 30729791
Acad Radiol. 2017 Sep;24(9):1154-1161
pubmed: 28365235
Sci Rep. 2017 Dec 12;7(1):17425
pubmed: 29234165
Age Ageing. 2012 Mar;41(2):142-7
pubmed: 22345294
J Surg Res. 2019 May;237:3-11
pubmed: 30694788
Arch Gerontol Geriatr. 2019 Jul - Aug;83:204-210
pubmed: 31082565
J Phys Ther Sci. 2021 Mar;33(3):213-221
pubmed: 33814707
Anesthesiol Clin. 2015 Mar;33(1):17-33
pubmed: 25701926
Asia Pac J Clin Nutr. 2019;28(1):157-165
pubmed: 30896427
Arch Gerontol Geriatr. 2011 Jul-Aug;53(1):84-9
pubmed: 20678814